488 related articles for article (PubMed ID: 31412635)
21. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
[TBL] [Abstract][Full Text] [Related]
22. Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2-NF-κB and JNK-AP-1 signaling pathways.
Adamopoulos C; Piperi C; Gargalionis AN; Dalagiorgou G; Spilioti E; Korkolopoulou P; Diamanti-Kandarakis E; Papavassiliou AG
Cell Mol Life Sci; 2016 Apr; 73(8):1685-98. PubMed ID: 26646068
[TBL] [Abstract][Full Text] [Related]
23. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
[TBL] [Abstract][Full Text] [Related]
24. [Correlation of the expressions of advanced glycation end products and its receptor in serum and placenta with the pathogenesis of preeclampsia].
Xian N; Chen W; Zhang Y; Li J; Zhang N; Ye Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):493-9. PubMed ID: 26311638
[TBL] [Abstract][Full Text] [Related]
25. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
26. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
27. Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease.
Tsirebolos G; Tsoporis JN; Drosatos IA; Izhar S; Gkavogiannakis N; Sakadakis E; Triantafyllis AS; Parker TG; Rallidis LS; Rizos I
Int J Cardiol; 2023 Apr; 376():127-133. PubMed ID: 36758863
[TBL] [Abstract][Full Text] [Related]
28. Soluble receptor for advanced glycation end products as a vasculopathy biomarker in sickle cell disease.
Safwat NA; Kenny MA
Pediatr Res; 2018 Dec; 84(6):869-874. PubMed ID: 30367158
[TBL] [Abstract][Full Text] [Related]
29. Relationships between vitreous levels of soluble receptor for advanced glycation end products (sRAGE) and renal function in patients with diabetic retinopathy.
Katagiri M; Shoji J; Kato S; Kitano S; Uchigata Y
Int Ophthalmol; 2017 Dec; 37(6):1247-1255. PubMed ID: 27830398
[TBL] [Abstract][Full Text] [Related]
30. Advanced glycation end products on stored red blood cells increase endothelial reactive oxygen species generation through interaction with receptor for advanced glycation end products.
Mangalmurti NS; Chatterjee S; Cheng G; Andersen E; Mohammed A; Siegel DL; Schmidt AM; Albelda SM; Lee JS
Transfusion; 2010 Nov; 50(11):2353-61. PubMed ID: 20492604
[TBL] [Abstract][Full Text] [Related]
31. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study.
Sabbatinelli J; Castiglione S; Macrì F; Giuliani A; Ramini D; Vinci MC; Tortato E; Bonfigli AR; Olivieri F; Raucci A
Cardiovasc Diabetol; 2022 Jun; 21(1):95. PubMed ID: 35668468
[TBL] [Abstract][Full Text] [Related]
32. Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.
Nakamura K; Yamagishi S; Nakamura Y; Takenaka K; Matsui T; Jinnouchi Y; Imaizumi T
Microvasc Res; 2005 Nov; 70(3):137-41. PubMed ID: 16271939
[TBL] [Abstract][Full Text] [Related]
33. Circulating soluble RAGE and cell surface RAGE on peripheral blood mononuclear cells in healthy children.
García-Salido A; Melen G; Gómez-Piña V; Oñoro-Otero G; Serrano-González A; Casado-Flores J; Ramírez M
J Pediatr Endocrinol Metab; 2018 Jun; 31(6):649-654. PubMed ID: 29723156
[TBL] [Abstract][Full Text] [Related]
34. Hemodialysis Patients with Higher Serum Levels of Soluble Receptor for Advanced Glycation End Products Have an Increased Risk for Arteriovenous Fistula Failure.
Ticala M; Rusu CC; Moldovan D; Potra AR; Tirinescu DC; Coman AL; Bondor CI; Budisan L; Kacsó IM
Blood Purif; 2022; 51(9):764-771. PubMed ID: 34794141
[TBL] [Abstract][Full Text] [Related]
35. Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker.
Yamagishi S; Matsui T
Front Biosci (Elite Ed); 2010 Jun; 2(4):1184-95. PubMed ID: 20515790
[TBL] [Abstract][Full Text] [Related]
36. Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome.
Selejan SR; Linz D; Tatu AM; Hohl M; Speer T; Ewen S; Mahfoud F; Kindermann I; Zamyatkin O; Kazakov A; Laufs U; Böhm M
J Mol Cell Cardiol; 2018 Sep; 122():34-46. PubMed ID: 30096408
[TBL] [Abstract][Full Text] [Related]
37. Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells.
Ren X; Ren L; Wei Q; Shao H; Chen L; Liu N
Cardiovasc Diabetol; 2017 Apr; 16(1):52. PubMed ID: 28427390
[TBL] [Abstract][Full Text] [Related]
38. miR-21-3p regulates AGE/RAGE signalling and improves diabetic atherosclerosis.
Shao M; Yu M; Zhao J; Mei J; Pan Y; Zhang J; Wu H; Yu M; Liu F; Chen G
Cell Biochem Funct; 2020 Oct; 38(7):965-975. PubMed ID: 32196704
[TBL] [Abstract][Full Text] [Related]
39. AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.
Prasad K
Mol Cell Biochem; 2019 Sep; 459(1-2):95-112. PubMed ID: 31079281
[TBL] [Abstract][Full Text] [Related]
40. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
